HPMA based amphiphilic copolymers mediate central nervous effects of domperidone.
Mirjam Hemmelmann, Christiane Knoth, Ulrich Schmitt, Mareli Allmeroth, Dorothea Moderegger, Matthias Barz, Kaloian Koynov, Christoph Hiemke, Frank Rösch, Rudolf Zentel
Index: Macromol. Rapid Commun. 32(9-10) , 712-7, (2011)
Full Text: HTML
Abstract
In this study we give evidence that domperidone encapsulated into amphiphilic p(HPMA)-co-p(laurylmethacrylate) (LMA) copolymer aggregates is able to cross the blood-brain barrier, since it affected motor behaviour in animals, which is a sensitive measure for CNS actions. Carefully designed copolymers based on the clinically approved p(HPMA) were selected and synthesized by a combination of controlled radical polymerization and post-polymerization modification. The hydrodynamic radii (R(h) ) of amphiphilic p(HPMA)-co-p(LMA) alone and loaded with domperidone were determined by fluorescence correlation spectroscopy.Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Related Compounds
Related Articles:
2012-10-28
[J. Control. Release 163(2) , 170-7, (2012)]
2012-12-10
[Biomacromolecules 13(12) , 4065-74, (2012)]
2013-09-01
[Biomaterials 34(27) , 6528-38, (2013)]
2012-10-10
[J. Control. Release 163(1) , 63-74, (2012)]
Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.
2012-03-12
[Biomacromolecules 13(3) , 727-35, (2012)]